new icn messageflickr-free-ic3d pan white
2018.10.24 Low Carb and Low Carbon 573 | by tedeytan
Back to photostream

2018.10.24 Low Carb and Low Carbon 573

The 2018 Management of Hyperglycemia in Type 2 Diabetes, 2018 indicates progress in finally acknowledging alternative dietary approaches to therapeutic nutrition (referred to as “Medical Nutrition Therapy” or MNT”)

 

However:

Lifestyle modifications, cited as first line therapy, are discussed after 11 pages of pharmacologic therapy

There are significant and extensive “duality of interest” (conflict of interest) disclosures by the author (payments from pharmaceutical interests)

Additionally:

Studies cited are cherry-picked

Different standards are applied to DASH (without long term data) vs Low-Carbohydrate approaches (with long term data)

Dietary standards established for healthy people are used inappropriately in this audience with chronic illness

 

Source: Davies MJ, D’Alessio DA, Fradkin J, Kernan WN, Mathieu C, Mingrone G, et al. Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care [Internet]. 2018 Oct 4;dci180033. Available from: doi.org/10.2337/dci18-0033

124 views
1 fave
0 comments
Uploaded on October 25, 2018